Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 209 for “"HPV16"”.

  1. Tp53 and Hras Influence on HPV16 E7 Expression in HPV16-Transformed Human Keratinocytes

    … in Human Keratinocyte lines transformed with HPV16 (HKc/HPV16) and their respective HKc/DR cells lines, and to assess the effect of p53 knock-down on the response of HKc/HPV16 to UV.

    south-carolina Repository record for Tp53 and Hras Influence on HPV16 E7 Expression in HPV16-Transformed Human Keratinocytes (opens in a new tab)

  2. Small Molecule Inhibitors of HPV16 E6

    High-risk human papillomaviruses (HR-HPVs) cause nearly all cases of cervical cancer. HPV 16 E6, one of two viral oncogenes, protects cells from apoptosis by binding to and accelerating the degradation of several apoptotic proteins, including caspase 8 and p53. We proposed that blocking the …

    loma-linda Repository record for Small Molecule Inhibitors of HPV16 E6 (opens in a new tab)

  3. Regulation of HPV16 Early Gene Expression

    Human papillomavirus type 16 (HPV16) is the most common high-risk type and isassociated with more than 50% cervical cancer cases as well as a number of headand neck cancer cases. The life cycle of HPV16 is strictly linked to celldifferentiation in the squamous epithelium with expression of the …

    lund Repository record for Regulation of HPV16 Early Gene Expression (opens in a new tab) Download PDF for Regulation of HPV16 Early Gene Expression (opens in a new tab)

  4. Anti-tumor Mechanisms of HPV16 E6*

    … in vivo. To test this prediction, we injected HPV16+ SiHa and HPV16- C33A cervical cancer cells overexpressing E6* into nude mice and monitored tumor growth over several weeks while comparing them with control tumors lacking E6* overexpression. E6* was found to reduce growth in both SiHa- and …

    loma-linda Repository record for Anti-tumor Mechanisms of HPV16 E6* (opens in a new tab)

  5. HPV16 E6* Induces Oxidative Stress and DNA Damage

    <p>High risk types of Human Papillomavirus are the causative agents of virtually all cases of cervical cancer, 50-90% of other anogenital cancers and approximately 30% of oral and pharyngeal cancers. The high-risk types encode two viral oncogenes, E6 and E7, which work together to initiate cell …

    loma-linda Repository record for HPV16 E6* Induces Oxidative Stress and DNA Damage (opens in a new tab)

  6. DNA fusion vaccines against HPV16 E7 antigen-associated cancers

    … DNA fusion vaccines against the E7 antigen from HPV16 were constructed, including pDOM.E749-57, which encodes a well described H-2Db-binding epitope from E7 fused to the DOM sequence. CD8+ T-cell responses to the vaccines were demonstrated using flow cytometry and functional assays. Importantly, …

    soton Download PDF for DNA fusion vaccines against HPV16 E7 antigen-associated cancers (opens in a new tab)

  7. Investigation of the Interactions Between the DREAM Complex and HPV16

    … mouse fibroblasts, all of which contained the HPV16 genome, as models to observe the effects of the LIN52-S20C mutation on HPV-mediated hijacking of the cell cycle. Not only were we able to replicate the increased proliferation and upregulated DREAM gene expression in infected cells, but we …

    vcu Repository record for Investigation of the Interactions Between the DREAM Complex and HPV16 (opens in a new tab)

  8. Investigation of HPV16-related genomic alterations in cervical squamous cell carcinoma

    This study examined the effects of human papillomavirus genomic integration into the host genome on host gene expression in cervical squamous cell carcinoma (CSCC) tumors. The genomic analysis involved clinical and genomics data analysis using bioinformatics and statistical methods. The Cancer …

    umkc Repository record for Investigation of HPV16-related genomic alterations in cervical squamous cell carcinoma (opens in a new tab)

  9. Molecular Mechanisms of Loss of E7 Expression in HPV16 – Transformed Human Keratinocytes

    … the p53 gene in differentiation-resistant HPV16 immortalized human keratinocytes (HKc-DR). The DNA deletions within the p53 gene were confirmed by PCR and gel electrophoresis and further validated by Sanger sequencing. Using qPCR, we found that HPV16 E7 expression was significantly lower …

    south-carolina Repository record for Molecular Mechanisms of Loss of E7 Expression in HPV16 – Transformed Human Keratinocytes (opens in a new tab)

  10. Cellular and Viral Factors Important for Entry and Retrograde Trafficking of HPV16

    There are at least 400 types of human papillomaviruses (HPV) have been identified. HPVs infection is the most sexually transmitted disease in the US. Most of the HPVs are commensal or low-risk HPVs that cause either asymptomatic infection or benign skin and genital warts. However, about 17 types …

    arizona-thes Repository record for Cellular and Viral Factors Important for Entry and Retrograde Trafficking of HPV16 (opens in a new tab)

  11. Evaluation of Adenovirus recombinants displaying a cross-protective HPV16 L2 epitope in mice.

    … encapsidating a luciferase reporter, first with HPV16 pseudovirus and then heterologously with HPV56 pseudovirus. The data show that mice were protected against high dose infection with HPV16; however there was no protection in the heterologous challenge with HPV56. The data demonstrate that …

    jhu Repository record for Evaluation of Adenovirus recombinants displaying a cross-protective HPV16 L2 epitope in mice. (opens in a new tab)

  12. Analysis of HPV16 Variants in the Carolina Women’s Care Study and a Comparison of Gene Expression Profiles of Exfoliated Cervical Cells From Women Who Either Clear or Do Not Clear an HPV16 Infection

    … agent for cervical cancer with HPV type 16 (HPV16) being found in about 50% of cervical cancers worldwide. HPVs vary in genomic (DNA) sequence not only between types, but also within types, known as variants. Variants of a particular HPV type may differ by up to 2% in nucleotide sequence in …

    south-carolina Repository record for Analysis of HPV16 Variants in the Carolina Women’s Care Study and a Comparison of Gene Expression Profiles of Exfoliated Cervical Cells From Women Who Either Clear or Do Not Clear an HPV16 Infection (opens in a new tab)

  13. Assessment of Circularized HPV16 E7 RNA, GLUT1, and PD-L1 in Anal Squamous Cell Carcinoma

    … discovered a novel circular E7 RNA expressed by HPV16 (circE7), which has not been assessed as a potential biomarker in any diseases. OBJECTIVE: We hypothesize that human papillomavirus infection status, increased GLUT-1 expression, increased PD-L1 expression, and HPV E7 RNA expression will serve …

    utswmed Repository record for Assessment of Circularized HPV16 E7 RNA, GLUT1, and PD-L1 in Anal Squamous Cell Carcinoma (opens in a new tab)

  14. GENERATION OF A SPONTANEOUS HPV16 E6/E7 EXPRESSING PRE-CLINICAL TUMOR MODEL FOR TESTING THERAPEUTIC INTERVENTIONS

    … arising from plasmid combination including HPV16 E6/E7, NRASG12V and transposase SB100, which is capable of metastasizing and is useful for testing immunotherapies. In Chapter 3, in order to improve the histologic characteristics of the spontaneous tumor described in Chapter 2, I utilize …

    jhu Repository record for GENERATION OF A SPONTANEOUS HPV16 E6/E7 EXPRESSING PRE-CLINICAL TUMOR MODEL FOR TESTING THERAPEUTIC INTERVENTIONS (opens in a new tab)

  15. SRPIN340, a cellular serine arginine protein kinases (SRPK) inhibitor, as a potential therapeutic for HPV16 infection

    High-risk human papillomavirus type 16 (HPV16) is the most prevalent HPV infection in the globe. Worldwide, persistent HPV16 infection is responsible for approximately 55-60% of cervical cancer cases, the fourth most common cancer in women with an estimated 570 000 new cases in 2018. The only …

    glasgow Repository record for SRPIN340, a cellular serine arginine protein kinases (SRPK) inhibitor, as a potential therapeutic for HPV16 infection (opens in a new tab)

  16. A NEW ROLE OF HPV16 E7 ONCOPROTEIN, INDEPENDENT OF POCKET PROTEINS, IN TRANSCRIPTIONAL ACTIVATION OF MITOTIC GENES

    High-risk human papillomaviruses (HPVs) are etiological agents of cervical cancers. Previous studies demonstrated that the viral oncoprotein E7 can up-regulate transcription of cellular E2F target genes and promote S-phase entry by subverting the pRB/E2F pathway. B-Myb and FoxM1 are major …

    nus Repository record for A NEW ROLE OF HPV16 E7 ONCOPROTEIN, INDEPENDENT OF POCKET PROTEINS, IN TRANSCRIPTIONAL ACTIVATION OF MITOTIC GENES (opens in a new tab) Download file for A NEW ROLE OF HPV16 E7 ONCOPROTEIN, INDEPENDENT OF POCKET PROTEINS, IN TRANSCRIPTIONAL ACTIVATION OF MITOTIC GENES (opens in a new tab)

  17. Humoral response to HPV16 proteins in patients with anal high-grade squamous intraepithelial lesion and anal cancer

    … intraepithelial lesion (HSIL) or cancer with HPV16 antibody detection and estimate predictive ability of HPV16 antibody levels to determine HSIL or cancer status. Design: This is a case-control study that included 67 cases of anal HSIL, 116 cancer cases, and 830 population-based matched …

    washington Repository record for Humoral response to HPV16 proteins in patients with anal high-grade squamous intraepithelial lesion and anal cancer (opens in a new tab)

  18. The cellular splicing regulator SRSF2 controls HPV16 E6 mRNA stability and contributes to the cervical tumour phenotype

    HPV16 is a double stranded DNA virus which has a close association with cervical cancer development. HPV16 expresses two oncoproteins E6 and E7, which when overexpressed transform the virus-infected epithelial cells. E6 and E7-encoding RNAs have been shown to be alternatively spliced to give at …

    glasgow Download PDF for The cellular splicing regulator SRSF2 controls HPV16 E6 mRNA stability and contributes to the cervical tumour phenotype (opens in a new tab)

Page 1 of 11